Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Aya Shibamiya"'
Autor:
Constantin von Bibra, Aya Shibamiya, Andrea Bähr, Birgit Geertz, Maria Köhne, Tim Stuedemann, Jutta Starbatty, Verena Horneffer-van der Sluis, Ulrich C. Klostermeier, Nadja Hornaschewitz, Xinghai Li, Eckhard Wolf, Nikolai Klymiuk, Markus Krane, Christian Kupatt, Bernhard Hiebl, Thomas Eschenhagen, Florian Weinberger
Publikováno v:
Disease Models & Mechanisms, Vol 16, Iss 5 (2023)
Externí odkaz:
https://doaj.org/article/b2f866000a454c14a8dba3101b884926
Autor:
Nele Warnecke, Bärbel M. Ulmer, Sandra D. Laufer, Aya Shibamiya, Elisabeth Krämer, Christiane Neuber, Sophia Hanke, Charlotta Behrens, Malte Loos, Julia Münch, Jirko Kühnisch, Sabine Klaassen, Thomas Eschenhagen, Monica Patten-Hamel, Lucie Carrier, Giulia Mearini
Publikováno v:
Stem Cell Research, Vol 55, Iss , Pp 102489- (2021)
MYBPC3 is the most frequently affected gene in hypertrophic cardiomyopathy (HCM), which is an autosomal-dominant cardiac disease caused by mutations in sarcomeric proteins. Bi-allelic truncating MYBPC3 mutations are associated with severe forms of ne
Externí odkaz:
https://doaj.org/article/823c7120cb5b4e818f122df69c905bed
Autor:
Maksymilian Prondzynski, Elisabeth Krämer, Sandra D. Laufer, Aya Shibamiya, Ole Pless, Frederik Flenner, Oliver J. Müller, Julia Münch, Charles Redwood, Arne Hansen, Monica Patten, Thomas Eschenhagen, Giulia Mearini, Lucie Carrier
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 7, Iss C, Pp 475-486 (2017)
Gene therapy is a promising option for severe forms of genetic diseases. We previously provided evidence for the feasibility of trans-splicing, exon skipping, and gene replacement in a mouse model of hypertrophic cardiomyopathy (HCM) carrying a mutat
Externí odkaz:
https://doaj.org/article/285f249a121446408d9780a45f0af2f9
Autor:
Tim Stüdemann, Judith Rössinger, Christoph Manthey, Birgit Geertz, Rajiven Srikantharajah, Constantin von Bibra, Aya Shibamiya, Maria Köhne, Antonius Wiehler, J. Simon Wiegert, Thomas Eschenhagen, Florian Weinberger
Publikováno v:
Circulation. 146(15)
Background: Transplantation of pluripotent stem cell–derived cardiomyocytes represents a promising therapeutic strategy for cardiac regeneration, and the first clinical studies in patients with heart failure have commenced. Yet, little is known abo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91c75386f2d5583ba56900d593822496
https://pubmed.ncbi.nlm.nih.gov/36073365
https://pubmed.ncbi.nlm.nih.gov/36073365
Autor:
Charlotta Sophie Behrens, Maximilian Kolbe, Julia Freese, Sophia Hanke, Maria Köhne, Andreas Huge, Aya Shibamiya, Arne Hansen, Lucie Carrier, Bärbel Ulmer, Thomas Eschenhagen
Publikováno v:
Journal of Molecular and Cellular Cardiology. 173:155-156
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29120090dae1a59e580a624dcac6c530
https://doi.org/10.1016/j.yjmcc.2022.08.307
https://doi.org/10.1016/j.yjmcc.2022.08.307
Autor:
Constantin von Bibra, Aya Shibamiya, Andrea Bähr, Birgit Geertz, Maria Köhne, Tim Stuedemann, Jutta Starbatty, Nadja Hornaschewitz, Xinghai Li, Eckhard Wolf, Nikolai Klymiuk, Markus Krane, Christian Kupatt, Bernhard Hiebl, Thomas Eschenhagen, Florian Weinberger
Engineered heart tissue (EHT) transplantation represents an innovative, regenerative approach for heart failure patients. Late preclinical trials are underway, and the first clinical trial has started in 2021. Preceding studies revealed functional re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::263d536fef4df3e794f69165ceae98a1
https://doi.org/10.1101/2022.07.07.499077
https://doi.org/10.1101/2022.07.07.499077
Autor:
Maria Köhne, Charlotta Sophie Behrens, Tim Stüdemann, Constantin von Bibra, Eva Querdel, Aya Shibamiya, Birgit Geertz, Jakob Olfe, Ida Hüners, Stefan Jockenhövel, Michael Hübler, Thomas Eschenhagen, Jörg Siegmar Sachweh, Florian Weinberger, Daniel Biermann
Publikováno v:
European journal of cardio-thoracic surgery 62(2), (2022). doi:10.1093/ejcts/ezac111
European journal of cardio-thoracic surgery 62(2), (2022). doi:10.1093/ejcts/ezac111
Published by Oxford Univ. Press, Oxford
Published by Oxford Univ. Press, Oxford
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::905ef2f096d428d62784805785e2a1ab
Autor:
Judith Rössinger, Tim Stüdemann, Aya Shibamiya, Torsten Christ, Thomas Eschenhagen, Florian Weinberger
Publikováno v:
Journal of Molecular and Cellular Cardiology. 173:56
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ac7a41126c564383855ac18c868fe8d
https://doi.org/10.1016/j.yjmcc.2022.08.109
https://doi.org/10.1016/j.yjmcc.2022.08.109
Autor:
Constantin von Bibra, Aya Shibamiya, Birgit Geertz, Eva Querdel, Maria Köhne, Tim Stüdemann, Jutta Starbatty, Felix N. Schmidt, Arne Hansen, Bernhard Hiebl, Thomas Eschenhagen, Florian Weinberger
Publikováno v:
Journal of molecular and cellular cardiology. 166
Myocardial injury leads to an irreversible loss of cardiomyocytes (CM). The implantation of human engineered heart tissue (EHT) has become a promising regenerative approach. Previous studies exhibited beneficial, dose-dependent effects of human induc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1556dd177308f463b6cbfe9ef7316695
https://pubmed.ncbi.nlm.nih.gov/35081367
https://pubmed.ncbi.nlm.nih.gov/35081367
Autor:
Bärbel M. Ulmer, Hermann Reichenspurner, Marina Reinsch, Nadja Hornaschewitz, Aya Shibamiya, Torsten Christ, Florian Weinberger, Markus Krane, Deniz Köse, Marc D Lemoine, Ingra Mannhardt, Jascha Sani, Tobias Krause, Tim Stüdemann, Svenja Reich, Marta Lemme, Andrea Bähr, Constantin V. von Bibra, Mirja L Schulze, Simon Pecha, Nikolai Klymiuk, Maria Köhne, Eva Querdel, Arne Hansen, Christian Kupatt, L. Castro, Birgit Geertz, Yusuf Nejahsie, Thomas Eschenhagen
Publikováno v:
Circulation
Supplemental Digital Content is available in the text.
Background: Human engineered heart tissue (EHT) transplantation represents a potential regenerative strategy for patients with heart failure and has been successful in preclinical models. Cl
Background: Human engineered heart tissue (EHT) transplantation represents a potential regenerative strategy for patients with heart failure and has been successful in preclinical models. Cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3aa857572c606377e8b8709c01c7cbe3
https://pubmed.ncbi.nlm.nih.gov/33999669
https://pubmed.ncbi.nlm.nih.gov/33999669